Enanta Pharmaceuticals (ENTA) Prepaid Assets (2012 - 2026)

Enanta Pharmaceuticals (ENTA) posted Prepaid Assets of $6.8 million for Q1 2026, up 56.84% on a QoQ basis from $4.3 million in Q4 2025, and down 23.11% year-over-year from $8.9 million in Q1 2025.

Enanta Pharmaceuticals (ENTA) Prepaid Assets (2012 - 2026) Analysis & Trends

Enanta Pharmaceuticals' Prepaid Assets history runs 15 years deep, the most recent figure standing at $6.8 million for Q1 2026.

  • Quarterly Prepaid Assets fell 23.11% year-over-year to $6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.8 million (down 23.11% YoY) and the FY2025 annual result came in at $8.6 million, down 30.8% from the prior year.
  • Prepaid Assets was $6.8 million for Q1 2026 at Enanta Pharmaceuticals, up from $4.3 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $17.9 million in Q4 2022 and bottomed at $4.3 million in Q4 2025.
  • A 5-year average of $12.0 million and a median of $12.4 million in 2024 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2022 — Prepaid Assets soared 55.97% — and 2025, when it tumbled 59.36%.
  • Enanta Pharmaceuticals' Prepaid Assets stood at $17.9 million in 2022, then fell by 26.2% to $13.2 million in 2023, then fell by 19.34% to $10.7 million in 2024, then plunged by 59.36% to $4.3 million in 2025, then surged by 56.84% to $6.8 million in 2026.
  • Business Quant data shows ENTA's Prepaid Assets at $6.8 million in Q1 2026, $4.3 million in Q4 2025, and $8.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Enanta Pharmaceuticals 376.07 Mn 212.29 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 6.81 Mn
Dec 31, 2025 4.34 Mn
Sep 30, 2025 8.59 Mn
Jun 30, 2025 10.24 Mn
Mar 31, 2025 8.86 Mn
Dec 31, 2024 10.68 Mn
Sep 30, 2024 12.41 Mn
Jun 30, 2024 15.26 Mn
Mar 31, 2024 10.93 Mn
Dec 31, 2023 13.25 Mn
Sep 30, 2023 13.26 Mn
Jun 30, 2023 17.07 Mn
Mar 31, 2023 14.48 Mn
Dec 31, 2022 17.95 Mn
Sep 30, 2022 13.45 Mn
Jun 30, 2022 11.54 Mn
Mar 31, 2022 14.08 Mn
Dec 31, 2021 11.51 Mn
Sep 30, 2021 14.19 Mn
Jun 30, 2021 12.14 Mn